CODX vs NOC · rev $3.9M vs P/E 17, rev $41.95B
Co-Diagnostics, Inc. Common Stock (CODX) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
CODX currently screens at market cap $31.4M. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the CODX and NOC stock pages for the full models.
Not investment advice.